Partner Elaine Blais has been recognized by World Intellectual Property Review (WIPR) as one of the most Influential Women in IP for 2021. The inaugural list honors trailblazing women around the world who represent the best and brightest lawyers in the field.
A firmwide leader, Blais is the head of Boston’s Litigation department and serves on Goodwin’s Executive Committee. She is also a member of the firm’s Intellectual Property Steering and Attorney Development Committees.
Blais focuses her practice on Intellectual Property Litigation, particularly Patent Litigation, and is known for her first-chair trial skills, strategic instincts, and experience in all areas of patent litigation including in the fields of biologics, pharmaceuticals, secure financial transactions, light-emitting diodes, and consumer products. She routinely represents clients in arbitration proceedings, and has first-chaired numerous lawsuits and taken cases to trial in federal courts nationwide.
Blais is the founder of Goodwin’s award-winning biosimilars blog Big Molecule Watch. In the community, she serves on the Kids in Need of Defense Boston Advisory Committee, the Boston Bar Association Council and the American Intellectual Property Law Association's Diversity, Equity and Inclusion Committee.
In recognition of these efforts, Blais has been recognized for excellence by The Legal 500 US, IAM Patent 1000 and Managing IP. Recently, she was named General Patent Litigator of the Year for New England by LMG Life Sciences. In 2017, Blais received the Boston Bar Association’s Thurgood Marshall Award for her unwavering commitment to community and pro bono work.